ema glp-1 vision loss recommendation november 2025 Ozempic Lawsuit [2026 Update] GLP-1 Agonists Weight Loss Drugs

Originally developed for diabetes, these drugs are now popular for weight loss, especially following expanded approval for adolescents.

Medicare beneficiaries will pay no more than $50 per monthfor approved treatments like Zepbound and Ozempic

Our job as clinicians is to protect what matters inside it

This review summarizes the existing knowledge derived from animal studies on the effects of GLP-1RAs and GLP-1RA related peptide polyagonists on NAFLD in an attempt to illuminate areas of uncertainty and provide the groundwork for future animal and clinical research in the field.

The current therapy associated with repeated subcutaneous injections to maintain the drug therapeutic effect causes patient compliance issues ...

Tirzepatide, a dual agonist of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide 1 (GLP-1) receptors, improved glucose control and...